University of Minnesota

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).

966 total trials 180 currently recruiting 671 completed early-phase tilt top decile by trial count

University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.

University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.

Top-decile sponsor footprint

University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

966 total, page 11 of 20

COMPLETED Phase 2

Naloxone, Hypoglycemia and Exercise

NCT03149770

COMPLETED NA

Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis

NCT03981406

COMPLETED NA

Health Wearables and College Student Health

NCT03253406

COMPLETED NA

Trial of a Health Promoting School Approach to Positive Youth Development and Wellness Promotion

NCT02840383

COMPLETED

Assessment of Brain Activities in Cervical Dystonia

NCT02959645

COMPLETED NA

Resident Physician Burnout and Well-being

NCT04125615

COMPLETED NA

Metabolic Impact of Time Restricted Feeding

NCT03129581

COMPLETED

TCA Cycle in the Dentate in Friedreich's Ataxia

NCT03122925

COMPLETED NA

The Efficacy of Osteopathic Manipulative Treatment (OMT) on the Golf Swing

NCT03241095

COMPLETED NA

Enhanced Nutrition for Preterm Infants

NCT03238768

COMPLETED Phase 1

State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With Deep Brain Stimulation (DBS)

NCT02709148

COMPLETED

Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders

NCT03033056

COMPLETED NA

Walking Green: Developing an Evidence-base for Nature Prescriptions

NCT03442998

COMPLETED

Role of Exogenous and Endogenous Sex Hormones on Tenofovir and Emtricitabine Disposition in Female Genital Tract

NCT03218085

COMPLETED

e-Cigarette - DNA Adducts

NCT03284632

COMPLETED

Brain-Behavior Interactions in Tic Suppression

NCT02205918

COMPLETED NA

SMART Optimization of a Parenting Program for Active-duty Families

NCT05509348

COMPLETED NA

Pressure-Volume Measurements on the AMS 800TM Cuff

NCT03122392

COMPLETED NA

The LoBAG Diet and Type 2 Diabetes Mellitus

NCT02717078

COMPLETED

Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients

NCT03170414

COMPLETED Phase 2

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

NCT03020719

COMPLETED

Is Cognitive Training Neuroprotective in Early Psychosis?

NCT03049800

COMPLETED

D2D Normative Data for Remote Assessments

NCT03206775

COMPLETED

The Sinonasal Cavity as a Reservoir for Upper Airway Bacterial Development

NCT03016689

COMPLETED NA

Low Intensity Blood Flow Restriction Training Study

NCT03055260

COMPLETED NA

Minnesota Community-Based Cognitive Training in Early Psychosis

NCT03079024

COMPLETED NA

Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial

NCT03149757

COMPLETED NA

Menthol Flavored E-cigarette Use During a Simulated Ban of Menthol Cigarettes

NCT03164668

COMPLETED NA

Use of an Occlusal Support Device During the Second Stage of Labor

NCT02807493

COMPLETED NA

Spinal Cord Stimulation to Treat Hypertension

NCT02828436

COMPLETED Phase 1

Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2

NCT03346499

COMPLETED Phase 2

Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias

NCT02837328

COMPLETED NA

Effect of Exercise on Perinatal Depression

NCT02791932

COMPLETED

Brain Functional Connectivity in Alcohol Use Disorder

NCT02877849

COMPLETED NA

Sucralose, Stevia, Gut Microbiome and Glucose Metabolism

NCT02800707

COMPLETED

Biology of Osteosarcoma (BOOST) Registry and Biobank

NCT03225872

COMPLETED Early Phase 1

A Clinical Comparison of FDA-Cleared Photobiomodulation Devices for the Treatment of Alopecia

NCT06748287

COMPLETED NA

MiCrobiome dieT Study

NCT03610477

COMPLETED NA

Home-based Non-invasive Brain Stimulation and Hand Tracking Rehabilitation for People With Chronic Stroke

NCT02460809

COMPLETED NA

rTMS in Spasmodic Dysphonia

NCT02957942

COMPLETED NA

Clinical Performance of a New Esthetic, Self-ligating Orthodontic Bracket

NCT02959671

COMPLETED

The Effects of Single-Pulse Transcranial Magnetic Stimulation on the Autonomic Nervous System in Healthy Adults

NCT02833220

COMPLETED NA

Dietary Impact on Intestinal Sulfate Metabolism

NCT05333900

COMPLETED NA

Hidrate Me Smart Water Bottle Use in Patient With Nephrolithiasis

NCT02938884

COMPLETED NA

The Residential Care Transition Module

NCT02915939

COMPLETED Phase 4

Anti-inflammatory Therapy to Improve Outcomes After TPIAT

NCT02713997

COMPLETED NA

Changes in Biomarkers Associated With Use of Electronic Cigarettes

NCT03084315

TERMINATED NA

Wellclub Shoulder Therapy Outcome Validation

NCT02954185

COMPLETED

Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations

NCT02761473

COMPLETED Early Phase 1

Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes

NCT02866435

← Previous Page 11 of 20 Next →

Phase Distribution

PhaseTrial count
Phase 1 123
Phase 2 83
Phase 3 35
Phase 4 36

What is open in the University of Minnesota pipeline

180 recruiting of 966 indexed (19% open); 671 completed (69%).

Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).

Top condition: Obesity (14 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Minnesota: open-pipeline peers nationwide

Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20% Total trials Recruiting share University of MinnesotaColumbia UniversityBrigham and Women's HospitalHoffmann-La RocheBristol-Myers SquibbUniversity of Alabama at BirminghamMclean HospitalChildren's Hospital Medical Center, CincinnatiArkansas Children's Hospital Research Institute
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 966 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Minnesota page

966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.

  • 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.